Polyclonal Anti-CCNB3 Antibody

cyclin B3
Recommended Applications
Product Description
Polyclonal Antibody against Human CCNB3
Product Number
Unit Size
Lot dependent
>10 in Stock
Ready to Ship
Target Protein
cyclin B3
Target Gene
Antigen Sequence
Recombinant Protein Epitope Signature Tag (PrEST) antigen sequence
Verified Species Reactivity
Interspecies Information

Highest antigen sequence identity to the following orthologs:

Rat ENSRNOG00000002951 (32%)

Mouse ENSMUSG00000051592 (29%)

40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative. Material Safety Data Sheet
Purification Method
Affinity purified using the PrEST antigen as affinity ligand
Gently mix before use. Optimal concentrations and conditions for each application should be determined by the user.
Unit Size
100 µl
Current Lot
Produced on demand. Contact support@atlasantibodies.com for more information.
Product Data Sheet
Immunohistochemistry (IHC)

Recommended conditions:

Dilution: 1:200 - 1:500

Retrieval method: HIER pH6

Immunofluorescence in Cell Lines (ICC-IF)

Recommended conditions:

Fixation/Permeabilization: PFA/Triton X-100

Working concentration: 0.25-2 µg/ml

Protein Name
cyclin B3
Gene Name
UniProt ID
Gene (Ensembl)
Entrez Gene ID
Normally shipped at ambient temperature
Store at +4°C for short term storage. Long time storage is recommended at -20°C.
Human Protein Atlas

This antibody has been used for staining of 44 normal human tissue samples as well as human cancer samples covering the 20 most common cancer types and up to 12 patients for each cancer type. The results are part of an ongoing effort to map the human proteome using antibodies.

All characterization data for ENSG00000147082 on the Human Protein Atlas

Suzuki K, Yasuda T, Haruhara Y, Watanabe K, Nomura K, Kanamori M, Kawaguchi Y

BCOR-CCNB3 sarcoma arising in the proximal tibia: A case report

Mol Clin Oncol , 2022 Feb 7; 16(4):77. Epub 2022 Feb 7

PubMed ID: 35251628 DOI: 10.3892/mco.2022.2510

Ichikawa D, Yamashita K, Okuno Y, Muramatsu H, Murakami N, Suzuki K, Kojima D, Kataoka S, Hamada M, Taniguchi R, Nishikawa E, Kawashima N, Narita A, Nishio N, Hama A, Kasai K, Mizuno S, Shimoyama Y, Nakaguro M, Okita H, Kojima S, Nakazawa A, Takahashi Y

Integrated diagnosis based on transcriptome analysis in suspected pediatric sarcomas

NPJ Genom Med , 2021 Jun 15; 6:49. Epub 2021 Jun 15

PubMed ID: 34131151 DOI: 10.1038/s41525-021-00210-y

Peters TL, Kumar V, Polikepahad S, Lin FY, Sarabia SF, Liang Y, Wang WL, Lazar AJ, Doddapaneni HV, Chao H, Muzny DM, Wheeler DA, Okcu MF, Plon SE, Hicks MJ, López-Terrada D, Parsons DW, Roy A

BCOR-CCNB3 Fusions Are Frequent in Undifferentiated Sarcomas of Male Children

Mod Pathol , 2015 Apr; 28(4):575-586. Epub 2014 Oct 31

PubMed ID: 25360585 DOI: 10.1038/modpathol.2014.139

Pierron G, Tirode F, Lucchesi C, Reynaud S, Ballet S, Cohen-Gogo S, Perrin V, Coindre JM, Delattre O

A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusion.

Nat Genet , 2012 Mar 4; 44(4):461-6. Epub 2012 Mar 4

PubMed ID: 22387997 DOI: 10.1038/ng.1107

Did we miss your publication?

Have you published using HPA000496? Please let us know and we will be happy to include your reference on this page.

Read more

Join the Explorer Program

Are you using our products in an application or species we have not yet tested? Why not participate in the Explorer Program, and we will show your contribution here. If you would like to share your results with us, the Explorer Program offers a 25µl vial free of charge with your next order.

Read more

Corresponding Antigens


Our customer support and expert scientific support teams are here to help you succeed in your research.

Get in touch